Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kasomeg
- Development stage
- Unknown
- Lead developer
- Kaiser Drugs
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kasomeg (also marketed as Kasomage) is a multi-ingredient nutraceutical supplement distributed by Kaiser Drugs. It is formulated as an oral softgel capsule containing a combination of Omega-3 fatty acids (Eicosapentaenoic acid and Docosahexaenoic acid), herbal extracts including Green Tea, Ginkgo Biloba, Ginseng, and Grape Seed, along with a comprehensive blend of vitamins, minerals, and trace elements. This formulation, often referred to in the Indian market as a '4G' or '5G' capsule, is intended to provide antioxidant support, improve cardiovascular health, enhance cognitive function, and boost overall physical stamina. The product acts through multiple pathways, including the modulation of lipid metabolism via PPAR-alpha activation and the mitigation of oxidative stress through its polyphenol and vitamin components.
- Brand names
- KasomegKasomage
Beyond the preview
Go deeper on Kasomeg.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kasomeg.